Shares Outstanding (Quarterly) Chart

View Shares Outstanding (Quarterly) for IDYA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shares Outstanding (Quarterly) Chart
Start Trial

Historical Shares Outstanding (Quarterly) Data

View and export this data back to 2018. Start Trial.
Date Value
June 30, 2026 96.38M
March 31, 2026 87.86M
December 31, 2025 87.80M
September 30, 2025 87.67M
June 30, 2025 87.64M
March 31, 2025 87.57M
December 31, 2024 86.50M
September 30, 2024 86.36M
June 30, 2024 76.09M
March 31, 2024 74.76M
December 31, 2023 65.04M
September 30, 2023 58.63M
June 30, 2023 57.44M
March 31, 2023 48.39M
December 31, 2022 48.19M
September 30, 2022 48.09M
June 30, 2022 38.70M
Date Value
March 31, 2022 38.64M
December 31, 2021 38.53M
September 30, 2021 38.46M
June 30, 2021 33.03M
March 31, 2021 32.27M
December 31, 2020 29.54M
September 30, 2020 29.07M
June 30, 2020 27.18M
March 31, 2020 20.35M
December 31, 2019 20.34M
September 30, 2019 20.33M
June 30, 2019 20.31M
March 31, 2019 20.23M
December 31, 2018 20.31M
September 30, 2018 20.23M
June 30, 2018 20.23M
March 31, 2018 20.23M

Shares Outstanding Definition

The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.

Read full definition.

Shares Outstanding (Quarterly) Range, Past 5 Years

View Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shares Outstanding (Quarterly) Benchmarks

View Shares Outstanding (Quarterly) Benchmarks
Start Trial
Xencor, Inc. 74.33M
UroGen Pharma Ltd. 48.87M
MeiraGTx Holdings Plc 94.19M
ACADIA Pharmaceuticals, Inc. 172.13M
Alnylam Pharmaceuticals, Inc. 133.73M